Rocket Pharmaceuticals Inc (NASDAQ:RCKT)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - RCKT

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - RCKT

  • Market Cap$1.518bn
  • SymbolNASDAQ:RCKT
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS77313F1066

Company Profile

Rocket Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency and RP-L4011 for Infantile Malignant Osteopetrosis.Rocket Pharmaceuticals Inc, formerly Inotek Pharmaceuticals Corp, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye.

Latest RCKT news

Currently there for this company. Visit our news hub for other news .